Agilent Life Sciences SSEL Cancer CGP Assay Probes DNA+RNA 96A
The Agilent SureSelect Cancer CGP Assay Probes DNA+RNA 96A (part number 5191-6992) is designed for comprehensive genomic profiling (CGP) of cancer samples. This product enables the simultaneous capture of DNA and RNA targets, facilitating the detection of a broad range of genomic alterations, including single nucleotide variants, insertions/deletions, copy number variations, and gene fusions. The kit is optimized for high-throughput workflows and is compatible with next-generation sequencing platforms, supporting up to 96 assays per kit. It is intended for use in research applications focused on oncology and precision medicine.